Qiagen NV (NYSE:QGEN) currently has a daily average trading volume of 1.35M but it saw 1384720 shares traded in last market. With a market cap of 8.66B USD, the company’s current market price of $40.05 came falling about -3.33 while comparing to the previous closing price of $41.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $47.92 and as low as $37.63. In the recent trading on the day, stock has struck highest price mark of $38.97 while lowest mark touched by it was $40.585.
Taking a look at 20-day trading activity of Qiagen NV (QGEN) gives us an average price of $39.76, while its current price level is -16.43% below from 52-week high level whereas it is 6.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $40.04 while that of 200 days or SMA-200 reads an average of $43.98. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.35% during that period while stretching the period over a month that decreases to 2.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.75 which implies that the stock is in neutral territory.
Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 19, 2025 while assigning a price target range of $52-$42. Morgan Stanley also issued its recommendations for the stock as it downgraded the price target for the stock is $48.
Over the week, QGEN’s stock price is moving -0.79% down while it is 1.65% when we observe its performance for the past one month. Year-to-date it is -10.05% down and over the past year, the stock is showing a downside performance of -4.56%.
The company is expected to be releasing its next quarterly report on 2025-Feb-04, for which analysts forecasted an EPS of 0.49 while estimate for next year EPS is 2.29. In next quarter, company is expected to be making quarterly sales of $506.25M as analysts are expecting the sales for current fiscal year at $2.04B and seeing the company making $2.17B in sales next year. Moreover, analysts are in estimates of $465.66M for current-quarter revenue.
Currently, Qiagen NV’s total number of outstanding shares is 216.12M with 1.96% of that held by the insiders while 62.08% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 1.67% and return on equity (ROE) at 2.27%. It has a price to earnings ratio (P/E ratio) of 107.81 while having a 16.20 of forward P/E ratio. Stock’s beta reads 0.67. Stock has a price to book (P/B) ratio of 2.43 while price to sale or P/S ratio amounts to 4.38. Its return on asset (ROA) is 1.42% on average.
